173913-66-1

Basic information

• Product Name: (2S,4R)-N-Boc-4-hydroxy-3,3-dimethylpyrrolidine-2-carboxylic acid
• Synonyms: (2s,4r)-n-boc-4-hydroxy-3,3-dimethylpyrrolidine-2-carboxylic acid;(2S,4R)-1-(tert-Butoxycarbonyl)-4-hydroxy-3,3-dimethylpyrrolidine-2-carboxylic acid;(2S,4R)-4-Hydroxy-3,3-dimethyl-1,2-pyrrolidinedicarboxylic acid 1-(1,1-dimethylethyl) ester
• CAS NO: 173913-66-1
• Molecular Formula: C12H21NO5
• Molecular Weight: 259.3
• Mol File: 173913-66-1.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 392.123 °C at 760 mmHg
• Flash Point: 190.95 °C
• Appearance: /
• Density: 1.208
• CAS DataBase Reference: (2S,4R)-N-Boc-4-hydroxy-3,3-dimethylpyrrolidine-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,4R)-N-Boc-4-hydroxy-3,3-dimethylpyrrolidine-2-carboxylic acid(173913-66-1)
• EPA Substance Registry System: (2S,4R)-N-Boc-4-hydroxy-3,3-dimethylpyrrolidine-2-carboxylic acid(173913-66-1)

Safety Data

• Hazardous Substances Data: 173913-66-1(Hazardous Substances Data)

Usage

General Description

"(2S,4R)-N-Boc-4-hydroxy-3,3-dimethylpyrrolidine-2-carboxylic acid" is a compound with a molecular formula C14H25NO5. It is a derivative of the amino acid proline, which is commonly found in collagen and other proteins. (2S,4R)-N-Boc-4-hydroxy-3,3-dimethylpyrrolidine-2-carboxylic acid is specifically designed for use in organic synthesis, particularly in the pharmaceutical industry where it may be used as a building block for the synthesis of complex molecules. The (2S,4R) stereochemistry indicates the specific spatial arrangement of atoms within the molecule, which is important for its reactivity and biological activity. The presence of the N-Boc (tert-butoxycarbonyl) protecting group ensures that the molecule reacts only at specific sites, providing greater control over its chemical transformations. Overall, this compound is a valuable tool for chemists and researchers working on the synthesis of biologically active molecules.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 173913-64-9 (2S,4R)-3,3-dimethyl-4-hydroxy-N-(9-phenylfluoren-9-yl)proline benzyl ester 
• 1367552-51-9 (S)-di-tert-butyl 3,3-dimethyl-4-oxopyrrolidine-1,2-dicarboxylate 
• 478700-27-5 (S)-1-(tert-butoxycarbonyl)-3,3-dimethyl-4-oxopyrrolidine-2-carboxylic acid 
• 173913-63-8 (2S)-3,3-dimethyl-4-oxo-N-(9-phenylfluoren-9-yl)proline benzyl ester 

Relevant articles and documents

SUBSTITUTED PROLINE INHIBITORS OF HEPATITIS C VIRUS REPLICATION

The embodiments provide compounds of the general Formulae I, la, II,IIa,III, IIIa, Illb, IV, IVa, IVb, V, Va, Vb, VI, VIa, VIb, and VIc, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition. The embodiments also provide methods for the synthesis of subject compounds and intermediates in the synthetic methods.